发明名称 Calcium channel blockers
摘要 <CHEM> <??>Compounds of formula (1) wherein m is 0, 1 or 2; wherein when m is 0, Z is 0; when m is 1, Z is N, and when m is 2, Z is C; Y is H, OH, NH2, or an organic moiety of 1-20C, optionally additionally containing 1-8 heteroatoms selected from the group consisting ofN, P, O, S and halo; each 1<1> and 1<2> is independently 0-5; 1<3> is 0 or 1; each of R<1>, R<2> and R<3> is independently alkyl (1-6C), aryl (6-10C) or arylalkyl (7-16C) optionally containing 1-4 heteroatoms selected from the group consisting of halo, N, P, O and S or each of R<1> and R<2> may independently be halo, COOR, CONR2, CF3, CN or NO2, wherein R is H or lower alkyl (1-4C) or alkyl (1-6C); n is 0 or 1; X is a linker; with the proviso that Y is not a tropolone, a coumarin, or an antioxidant containing an aromatic group and with the further proviso that if 1<3> is 0, neither R<1> nor R<2> can represent F in the para position; and are useful as calcium channel blockers. Libraries of these compounds can also be used to identify antagonists for other targets.
申请公布号 EP1466605(A2) 申请公布日期 2004.10.13
申请号 EP20040076808 申请日期 1999.06.30
申请人 NEUROMED TECHNOLOGIES INC. 发明人 SNUTCH, TERRANCE PRESTON;ZAMPONI, GERALD WERNER
分类号 C12Q1/02;A61K31/4427;A61K31/445;A61K31/4468;A61K31/451;A61K31/4515;A61K31/454;A61K31/4545;A61K31/495;A61K31/496;A61K31/498;A61K31/506;A61K31/535;A61K31/5375;A61K31/538;A61K31/5415;A61P9/00;A61P9/10;A61P9/12;A61P25/00;A61P25/04;A61P25/08;A61P29/00;A61P43/00;C07D211/14;C07D211/16;C07D211/46;C07D211/58;C07D239/42;C07D241/04;C07D295/02;C07D295/03;C07D295/18;C07D295/22;C07D401/04;C07D401/14 主分类号 C12Q1/02
代理机构 代理人
主权项
地址